The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 415-421

  Brügger Andersen, Trygve ^a,b   Hetland, Øyvind ^b   Pönitz, Volker ^a,b   Grundt, Heidi ^a,b   Nilsen, Dennis W T ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myocardial infarction; Biomarkers; Myeloperoxidase; Pregnancy associated plasma protein A (PAPP A); Revascularization therapy; Soluble fibrin and D dimer

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; MYELOPEROXIDASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; SMOKING; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ENOXAPARIN; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SOLUBILITY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 33846486780     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.03.009     Document Type: Article

References (33)

1. 2001 heart and stroke statistical update (2000), American Heart Association, Dallas
2. Davies M.J., Richardson P.D., Woolf N., Katz D.R., and Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69 (1993) 377-381
3. Richardson P.D., Davies M.J., and Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2 (1989) 941-944
4. Yeghiazarians Y., Braunstein J.B., Askari A., and Stone P.H. Unstable angina pectoris. N Engl J Med 342 (2000) 101-114
5. ISIS 2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17.817 cases of suspected acute myocardial infarction. Lancet 2 (1988) 349-360
6. Waters R.E., Mahaffey K.W., Granger C.B., and Roe M.T. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Am Heart J 146 (2003) 958-968
7. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
8. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
9. Klebanoff S.J. Myeloperoxidase. Proc Assoc Am Physicians 111 (1999) 383-389
10. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R.L., Hajjar D.P., et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 105 (2000) 1095-1108
11. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276 (2001) 41279-41287
12. Abu-Soud H.M., and Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 275 (2000) 37524-37532
13. Laursen L.S., Overgaard M.T., Nielsen C.G., Boldt H.B., Hopmann K.H., Conover C.A., et al. Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 367 (2002) 31-40
14. Bayes-Genis A., Schwartz R.S., Lewis D.A., Overgaard M.T., Christiansen M., Oxvig C., et al. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21 (2001) 335-341
15. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., and Holmes Jr. D.R. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
16. Caliezi C., Fünfsinn N., Mauron T., Baumgartner I., Sulzer I., Ulrich M., et al. Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients. Thromb Haemost 81 (1999) 50-53
17. Hetland Ø., Knudsen A., Dickstein K., and Nilsen D.W. Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. Blood Coagul Fibrinolysis 13 (2002) 301-308
18. Kruskal J.B., Commerford P.J., Franks J.J., and Kirsch R.E. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 26 (1987) 1361-1365
19. Brill-Edwards P., and Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost 82 (1999) 688-694
20. World Health Organisation. Myocardial infarction community registers (1976), World Health Organisation, Copenhagen
21. Fernández-Ortiz A., Badimon J.J., Falk E., Fuster V., Meyer B., Mailhac A., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23 (1994) 1562-1569
22. Merino A., Cohen M., Badimon J.J., Fuster V., and Badimon L. Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. J Am Coll Cardiol 24 (1994) 1091-1097
23. Lew A.S., Berberian L., Cercek B., Lee S., Shah P.K., and Ganz W. Elevated serum D-dimer: a degradation product of crosslinked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction. J Am Coll Cardiol 7 (1986) 1320-1324
24. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
25. Jones J.I., Prevette T., Gockerman A., and Clemmons D.R. Ligand occupancy of the alfaVbeta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A 93 (1996) 2482-2487
26. Renier G., Clement I., Desfaits A.C., and Lambert A. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alfa production. Endocrinology 137 (1996) 4611-4618
27. Cosin-Sales J., Kaski J.C., Christiansen M., Kaminski, Oxvig C., Overgaard M.T., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 26 (2005) 2093-2098
28. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569
29. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
30. Goldstein J.A., Demetriou D., Grines C.L., Pica M., Shoukfeh M., and O'Neill W.W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343 (2000) 915-922
31. 1. Am Heart J 132 (1996) 747-7
32. Brennan M., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
33. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., and Pettersson K. Molecular distinction of circulating pregnancy associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 51 (2005) 75-83